The World of Health & Medicine News

South Sudan cholera patients died walking to clinic after US cut aid, charity says

South Sudan cholera patients died walking to clinic after US cut aid, charity says

Eight people in South Sudan, including five children, died on a three-hour walk to seek medical treatment for cholera after U.S. aid cuts forced local health services to close, the UK-based charity Save the Children said on Wednesday.

The deaths last month are among the first to be directly attributed to cuts imposed by U.S. President Donald Trump after entering office on January 20, which he said were to ensure grants were aligned with his “America First” agenda.

“There should be global moral outrage that the decisions made by powerful people in other countries have led to child deaths in just a matter of weeks,” said Christopher Nyamandi, Save the Children’s country director in South Sudan.

Experts have warned that the cuts – including the cancellation of more than 90% of USAID’s contracts – could cost millions of lives in the coming years due to malnutrition, AIDS, tuberculosis, malaria and other diseases.

The U.S. State Department said it did not have information about the deaths reported by Save the Children. A spokesperson said many U.S government programmes providing lifesaving aid in South Sudan remained active but that support for medical services had also been used to enrich the country’s leaders.

“While emergency lifesaving programmes continue, we will not, in good conscience, ask the American taxpayer to provide assistance that effectively subsidises the irresponsible and corrupt behaviour of South Sudan’s political leaders,” the spokesperson said.

South Sudan’s government has in the past acknowledged a significant amount of public corruption but denied specific accusations of graft, including against President Salva Kiir’s family.

Humanitarian aid to the country is often channelled through non-governmental organisations, largely because of corruption concerns.

Save the Children supported 27 health facilities in eastern South Sudan’s Jonglei State until earlier this year when the U.S. cuts forced seven to shut completely and 20 to close partially, the organisation said in a statement.

U.S. funded transport services to take people to hospital in the main local town also stopped for lack of funds, which meant the eight cholera patients had to walk in nearly 40°C (104°F) heat to seek treatment at the nearest health facility, it said.

Three of the children were under the age of 5, Nyamandi said.

Besides the U.S. cuts, more gradual reductions by other donors have strained the humanitarian response in South Sudan. Save the Children expects to spend $30 million in the country in 2025, down from $50 million last year, Nyamandi said.

Over a third of South Sudan’s roughly 12 million people have been displaced by either conflict or natural disaster, and the United Nations says the country could be on the brink of a new civil war after fighting broke out in February in the northeast.

A cholera outbreak was declared last October. More than 22,000 cases had been recorded as of last month, causing hundreds of deaths, the World Health Organization has said.

spot_img

Explore more

spot_img

Rhythm Pharma’s drug for rare obesity meets late-stage trial goal

Rhythm Pharma's drug for rare obesity meets late-stage trial goal Rhythm Pharmaceuticals (RYTM.O), opens new tab said on Monday its drug Imcivree notably reduced weight in patients...

US FDA to phase out animal testing in drug development

US FDA to phase out animal testing in drug development The U.S. Food and Drug Administration said on Thursday it plans to replace animal...

US FDA approves syringe version of Argenx’s immune disorder drug

US FDA approves syringe version of Argenx's immune disorder drug The U.S. Food and Drug Administration has approved a prefilled syringe version of Netherlands-based Argenx...

Post-trauma drug blocks fear response in female mice, study shows

Post-trauma drug blocks fear response in female mice, study shows A new report published in Brain Medicine reveals that a single dose of the drug Osanetant, administered...

AstraZeneca And Daiichi Sankyo’s Enhertu Approved In EU For Advanced Breast...

AstraZeneca And Daiichi Sankyo's Enhertu Approved In EU For Advanced Breast Cancer Treatment AstraZeneca Plc. (AZN.L,AZN) and Daiichi Sankyo's (DSKYF.PK) Enhertu (trastuzumab deruxtecan) has been...

Mexico reports first human death from H5N1 bird flu

Mexico reports first human death from H5N1 bird flu Mexico on Tuesday logged its first human death from H5N1 avian influenza, a three-year-old girl in...

Plant-based pill shows promise in type 2 diabetes treatment

Plant-based pill shows promise in type 2 diabetes treatment A recent clinical trial has found that a plant-based pill could offer a promising new treatment...

With giant cell arteritis nod, AbbVie’s Rinvoq reaches eight approved uses...

With giant cell arteritis nod, AbbVie's Rinvoq reaches eight approved uses in EU AbbVie announced Tuesday the European Commission (EC) authorised Rinvoq (upadacitinib) as the...